XML 22 R12.htm IDEA: XBRL DOCUMENT v3.20.2
Earnings Per Share
9 Months Ended
Sep. 30, 2020
Earnings Per Share  
Earnings Per Share

5.    Earnings Per Share

Net income per common share attributable to Bruker Corporation shareholders is calculated by dividing net income attributable to Bruker Corporation, adjusted to reflect changes in the redemption value of the redeemable noncontrolling interest, by the weighted-average number of shares outstanding during the period. The diluted net income per share computation includes the effect of shares which would be issuable upon the exercise of outstanding stock options and the vesting of restricted stock, reduced by the number of shares which are assumed to be purchased by the Company under the treasury stock method. In January 2020, the Company acquired the remaining interest in our redeemable noncontrolling interest. There was no redemption value adjustment of the redeemable noncontrolling interest for the three and nine months ended September 30, 2020 or 2019.

The following table sets forth the computation of basic and diluted weighted average shares outstanding and net income per common share attributable to Bruker shareholders (dollars in millions, except per share amounts):

Three Months Ended September 30, 

Nine Months Ended September 30, 

    

2020

    

2019

    

2020

    

2019

Net income attributable to Bruker Corporation, as reported

$

54.3

$

61.3

$

88.9

$

128.6

Weighted average shares outstanding:

Weighted average shares outstanding-basic

 

153.2

 

154.2

 

153.7

 

155.7

Effect of dilutive securities:

Stock options and restricted stock awards and units

 

1.1

 

1.4

 

1.1

 

1.3

Weighted-average number of common shares used in computing diluted net income per common share

 

154.3

 

155.6

 

154.8

 

157.0

Net income per common share attributable to Bruker Corporation shareholders:

Basic

$

0.35

$

0.40

$

0.58

$

0.83

Diluted

$

0.35

$

0.39

$

0.57

$

0.82

The following common share equivalents have been excluded from the computation of diluted weighted-average shares outstanding, as their effect would have been anti-dilutive (amounts in millions of shares):

    

Three Months Ended September 30, 

    

Nine Months Ended September 30, 

    

2020

    

2019

    

2020

    

2019

Stock options

 

0.3

 

0.1

 

0.1

 

0.5

Unvested restricted stock units​

 

0.2

 

 

0.1